“…This is noteworthy, as the general opinion among experts is that CN is associated with good peripheral perfusion, possibly related to an inflammatory process ( Cates et al, 2019 ;Rogers and Laird, 2007 ). One group found no significant difference in the incidence of limb loss between patients with CN reconstruction whose diagnosis of PAD was made clinically or by angiography ( Cates et al, 2019 ). Orioli et al reported in an abstract that among 56 patients with Charcot foot, two-thirds of whom had infection, the prevalence of PAD was 66%, and it affected the infrapopliteal arteries more often than in diabetic foot patients without CN (23).…”
Section: Discussionmentioning
confidence: 83%
“…A previously unreported finding was identified that may be relevant to the management of patients with DCO: PAD was significantly associated with both overall clinical failure and major amputations. This is noteworthy, as the general opinion among experts is that CN is associated with good peripheral perfusion, possibly related to an inflammatory process ( Cates et al, 2019 ;Rogers and Laird, 2007 ). One group found no significant difference in the incidence of limb loss between patients with CN reconstruction whose diagnosis of PAD was made clinically or by angiography ( Cates et al, 2019 ).…”
Objective: Therapy for diabetic foot osteomyelitis (DFO) with Charcot neuroosteoarthropathy is challenging. In patients with diabetic Charcot osteomyelitis (DCO), both the anatomic deformity and infection must be addressed. This study assessed the outcomes of DCO therapy and variables associated with treatment failure and compared them with outcomes of DFO cases. Methods: A single-center, retrospective, case-control study was performed to compare 93 DCO episodes with 530 DFO episodes, using Kaplan-Meier survival curves and multivariate Cox regression analyses. Results: Clinical failure occurred in 21.5% of DCO compared with 22.3% in DFO episodes ( p = 0.89) and was associated with peripheral arterial disease (PAD) stages 3 or 4 (HR 6.1; CI 2.0-18.1) and chronic treatment with immunosuppressives (HR 7.4; CI 2.0-27.1). Major amputations were significantly more frequent in DCO (28% versus 13.6%; p < 0.01) and associated with PAD stages 3 and 4 (HR 8.0; CI 2.2-29.4), smoking (HR 5.4; CI 1.2-24.6), alcohol abuse (HR 3.5; CI 1.1-10.6), and renal dialysis (HR 4.9; CI 1.3-18.9). Conclusions: Clinical treatment failures did not differ between DCO and DFO. However, patients with DCO underwent major amputation twice as often as those with DFO. Unlike widespread belief, treatment failure in DCO patients may, similar to DFO, be associated with a striking epidemiological link to severe PAD.
“…This is noteworthy, as the general opinion among experts is that CN is associated with good peripheral perfusion, possibly related to an inflammatory process ( Cates et al, 2019 ;Rogers and Laird, 2007 ). One group found no significant difference in the incidence of limb loss between patients with CN reconstruction whose diagnosis of PAD was made clinically or by angiography ( Cates et al, 2019 ). Orioli et al reported in an abstract that among 56 patients with Charcot foot, two-thirds of whom had infection, the prevalence of PAD was 66%, and it affected the infrapopliteal arteries more often than in diabetic foot patients without CN (23).…”
Section: Discussionmentioning
confidence: 83%
“…A previously unreported finding was identified that may be relevant to the management of patients with DCO: PAD was significantly associated with both overall clinical failure and major amputations. This is noteworthy, as the general opinion among experts is that CN is associated with good peripheral perfusion, possibly related to an inflammatory process ( Cates et al, 2019 ;Rogers and Laird, 2007 ). One group found no significant difference in the incidence of limb loss between patients with CN reconstruction whose diagnosis of PAD was made clinically or by angiography ( Cates et al, 2019 ).…”
Objective: Therapy for diabetic foot osteomyelitis (DFO) with Charcot neuroosteoarthropathy is challenging. In patients with diabetic Charcot osteomyelitis (DCO), both the anatomic deformity and infection must be addressed. This study assessed the outcomes of DCO therapy and variables associated with treatment failure and compared them with outcomes of DFO cases. Methods: A single-center, retrospective, case-control study was performed to compare 93 DCO episodes with 530 DFO episodes, using Kaplan-Meier survival curves and multivariate Cox regression analyses. Results: Clinical failure occurred in 21.5% of DCO compared with 22.3% in DFO episodes ( p = 0.89) and was associated with peripheral arterial disease (PAD) stages 3 or 4 (HR 6.1; CI 2.0-18.1) and chronic treatment with immunosuppressives (HR 7.4; CI 2.0-27.1). Major amputations were significantly more frequent in DCO (28% versus 13.6%; p < 0.01) and associated with PAD stages 3 and 4 (HR 8.0; CI 2.2-29.4), smoking (HR 5.4; CI 1.2-24.6), alcohol abuse (HR 3.5; CI 1.1-10.6), and renal dialysis (HR 4.9; CI 1.3-18.9). Conclusions: Clinical treatment failures did not differ between DCO and DFO. However, patients with DCO underwent major amputation twice as often as those with DFO. Unlike widespread belief, treatment failure in DCO patients may, similar to DFO, be associated with a striking epidemiological link to severe PAD.
“…In the literature, the need for urgent surgery largely depends on the patient’s ischemic symptoms [ 32 ]. Some research groups suggest that undertaking early vascular interventions could increase the healing chances, especially in diabetic adults [ 8 , 19 , 20 , 30 ]. Others are less strict, advocating that patients benefitting from revascularization should be selected carefully, including considering the comorbidities, chances of success, and the likelihood of recovery from the infection [ 31 , 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…Many clinicians consider clinically significant peripheral artery disease (PAD) a particularly concerning risk for therapeutic failure in patients with DFIs [ 19 , 20 ]. The reduced blood supply impairs the wound healing [ 21 ] as well as the delivery of antibiotics to the infected site.…”
For ischemic diabetic foot infections (DFIs), revascularization ideally occurs before surgery, while a parenteral antibiotic treatment could be more efficacious than oral agents. In our tertiary center, we investigated the effects of the sequence between revascularization and surgery (emphasizing the perioperative period of 2 weeks before and after surgery), and the influence of administering parenteral antibiotic therapy on the outcomes of DFIs. Among 838 ischemic DFIs with moderate-to-severe symptomatic peripheral arterial disease, we revascularized 608 (72%; 562 angioplasties, 62 vascular surgeries) and surgically debrided all. The median length of postsurgical antibiotic therapy was 21 days (given parenterally for the initial 7 days). The median time delay between revascularization and debridement surgery was 7 days. During the long-term follow-up, treatment failed and required reoperation in 182 DFI episodes (30%). By multivariate Cox regression analyses, neither a delay between surgery and angioplasty (hazard ratio 1.0, 95% confidence interval 1.0–1.0), nor the postsurgical sequence of angioplasty (HR 0.9, 95% CI 0.5–1.8), nor long-duration parenteral antibiotic therapy (HR 1.0, 95% CI 0.9–1.1) prevented failures. Our results might indicate the feasibility of a more practical approach to ischemic DFIs in terms of timing of vascularization and more oral antibiotic use.
“…[15][16][17][18][19][20][21][22] These interventions include peripheral angioplasty, arteriovenous loops, bypass, or interposition grafting, and aim to re-establish vascular access to increase perfusion prior to a free tissue transfer. 23 Vascular surgeries such as arteriovenous loops, bypass, or interposition grafting are performed as a primary operation or during the free flap as an index procedure, with varying indications but also complications rates. [24][25][26] Recent studies have supported an "endovascular first" intervention approach, reporting high rates of salvage and excellent long-term prognosis when free flap transfer is used in combination with revascularization.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.